Evidence for CYP2D6 expression in human lung.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1997-12-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/BBRC.1997.7775PMID 9405237
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression and localization of CYP3A4 and CYP3A5 in human lung.

  1997cited by this paper
• Analysis of CYP2D6 expression in human lung: implications for the association between CYP2D6 activity and susceptibility to lung cancer.

  1997cited by this paper
• Comparisons of CYP2D messenger RNA splice variant profiles in human lung tumors and normal tissues.

  1997cited by this paper
• Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution.

  1997cited by this paper
• Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells.

  1996cited by this paper
• The effect of tobacco on lung cancer risk depends on CYP2D6 activity.

  1996cited by this paper
• Nomenclature for human CYP2D6 alleles.

  1996cited by this paper
• Lung cancer and CYP2D6 (the debrisoquine polymorphism): sources of heterogeneity in the proposed association.

  1995cited by this paper
• Metabolic polymorphisms and cancer susceptibility.

  1995cited by this paper
• Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review.

  1995cited by this paper
• Characterization of a Sulfotransferase from Human Airways Responsible for the 3-O-Sulfation of Terminal Galactose in N-Acetyllactosamine-containing Mucin Carbohydrate Chains (*)

  1995cited by this paper
• Molecular basis of polymorphic drug metabolism

  1995cited by this paper
• A novel CYP2D6 allele with an abolished splice recognition site associated with the poor metabolizer phenotype.

  1995cited by this paper
• Geographical/Interracial Differences in Polymorphic Drug Oxidation

  1995cited by this paper
• Metabolic polymorphisms in carcinogen metabolising enzymes and cancer susceptibility.

  1994cited by this paper
• Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors.

  1994cited by this paper
• Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.

  1994cited by this paper
• Metabolism and elimination of inhaled drugs and airborne chemicals from the lungs.

  1993cited by this paper
• Diverse role of pulmonary cytochrome P-450 monooxygenase.

  1992cited by this paper
• Cigarette smoking and lung cancer cell types

  1991cited by this paper
• LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.

  1991cited by this paper
• Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.

  1991cited by this paper
• Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism.

  1991cited by this paper
• A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6.

  1991cited by this paper
• Action by the lungs on circulating xenobiotic agents, with a case study of physiologically based pharmacokinetic modeling of benzo(a)pyrene disposition.

  1990cited by this paper
• Localization, distribution, and induction of xenobiotic-metabolizing enzymes and aryl hydrocarbon hydroxylase activity within lung.

  1990cited by this paper
• The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.

  1989cited by this paper

• Methamphetamine-associated pulmonary arterial hypertension

  2022cites this paper
• Drug Metabolism: Cytochrome P450

  2021cites this paper
• Xenobiotica-metabolizing enzymes in the lung of experimental animals, man and in human lung models

  2019cites this paper
• Circulating Extracellular Vesicles Containing Xenobiotic Metabolizing CYP Enzymes and Their Potential Roles in Extrahepatic Cells Via Cell–Cell Interactions

  2019cites this paper
• Reduced carboxylesterase 1 is associated with endothelial injury in methamphetamine-induced pulmonary arterial hypertension.

  2017cites this paper
• Original Article Interstitial lung disease caused by psychiatric drug therapy

  2016influential citation
• Leberfunktion im Früh- und Langzeitverlauf bis 1 Jahr nach Lebertransplantation und Lebensqualität vor und 1 Jahr nach Lebertransplantation

  2015cites this paper
• Drug Response Heterogeneity and the Genetic Variability of Cytochrome P450–Metabolizing Enzymes

  2014cites this paper
• Extrahepatic metabolism at the body's internal–external interfaces

  2014cites this paper
• Extrahepatic Drug-Metabolizing Enzymes and Their Significance

  2012cites this paper
• The prototypic pharmacogenetic drug debrisoquine is a substrate of the genetically polymorphic organic cation transporter OCT1.

  2012cites this paper
• Hepatocytes: the powerhouse of biotransformation.

  2012cites this paper
• Complementary products and drug interactions: screening for the potential to cause pharmacokinetic interactions

  2012cites this paper
• Contributions of human enzymes in carcinogen metabolism.

  2012cites this paper
• Angiogenesis regulation in hormone dependent breast- and ovarian cancer

  2011cites this paper
• Polymorphisms in interstitial lung diseases: Friend or foe.

  2011cites this paper
• Clinically relevant genetic variations in drug metabolizing enzymes.

  2011cites this paper
• Profiling gene expression of whole cytochrome P450 superfamily in human bronchial and peripheral lung tissues: Differential expression in non-small cell lung cancers.

  2010cites this paper
• Relationship between drug-induced interstitial lung diseases and cytochrome P450 polymorphisms

  2010cites this paper
• MECHANISMS OF VARIABILITY IN CYP2D6 METABOLISM: THE CONTRIBUTIONS OF POLYMORPHISMS, COPY NUMBER VARIATIONS AND microRNA

  2010cites this paper
• Potential roles of fibroblast growth factor-9 in the benzo(a)pyrene-induced invasion in vitro and the metastasis of human lung adenocarcinoma

  2010cites this paper
• Relationship between drug-induced interstitial lung diseases and CYP polymorphisms

  2010cites this paper
• Polymorphism of human cytochrome P450 enzymes and its clinical impact

  2009cites this paper
• Study on herb-drug interactions

  2009cites this paper
• Role of Cytochrome P450 Polymorphisms in the Development of Pulmonary Drug Toxicity

  2008cites this paper
• Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use.

  2008cites this paper
• Critical appraisal of the expression of cytochrome P450 enzymes in human lung and evaluation of the possibility that such expression provides evidence of potential styrene tumorigenicity in humans.

  2008cites this paper
• Biotransformation and DNA Repair in 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-Induced Pulmonary Carcinogenesis

  2008cites this paper
• Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determination.

  2006cites this paper
• Comparative cytochrome P450 ‐1A1, ‐2A6, ‐2B6, ‐2C, ‐2D6, ‐2E1, ‐3A5 and ‐4B1 expressions in human larynx tissue analysed at mRNA level

  2006cites this paper
• FUNCTIONAL ANALYSIS OF 5'-FLANKING REGION OF CYTOCHROME P450 GENES THROUGH MOLECULAR CLONING AND TRANSFECTION IN VITRO AND IN VIVO

  2005cites this paper
• Identification of a genotoxic mechanism for the carcinogenicity of the environmental pollutant and suspected human carcinogen o‐anisidine

  2005cites this paper
• Induction of fibroblast growth factor-9 and interleukin-1alpha gene expression by motorcycle exhaust particulate extracts and benzo(a)pyrene in human lung adenocarcinoma cells.

  2005cites this paper
• Bedeutung von Cytochrom-P450-Polymorphismen für Verlauf, Erfolg und Nebenwirkungen der Therapie mit Antidepressiva

  2005cites this paper
• Pulmonary hypertension as a result of drug therapy.

  2004cites this paper
• Bases científicas de las respuestas idiosincráticas en la terapéutica. I. El papel del gen CYP2D6

  2004cites this paper
• Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers.

  2004cites this paper
• Drug-Metabolizing Enzymes and P-Glycoprotein

  2004cites this paper
• Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts.

  2003cites this paper
• Coordinated intrahepatic and extrahepatic regulation of cytochrome P4502D6 in healthy subjects and in patients after liver transplantation

  2003cites this paper
• Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

  2003cites this paper
• Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.

  2003cites this paper
• Catalytic specificity of CYP2D isoforms in rat and human.

  2002cites this paper
• Discriminative quantification of cytochrome P4502D6 and 2D7/8 pseudogene expression by TaqMan real-time reverse transcriptase polymerase chain reaction.

  2002cites this paper
• CATALYTIC SPECIFICITY OF CYP 2 D ISOFORMS IN RAT AND HUMAN

  2002cites this paper
• Expression and Regulation of Xenobiotic-Metabolizing Cytochrome P450 (CYP) Enzymes in Human Lung

  2002cites this paper
• Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD.

  2001cites this paper
• The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine

  2001cites this paper
• INDUCTION OF CYTOCHROMES P 450 1 A 1 AND 1 B 1 BY EMODIN IN HUMAN LUNG ADENOCARCINOMA CELL LINE CL 5

  2001cites this paper
• XENOBIOTIC-METABOLIZING CYTOCHROME P 450 ENZYMES IN HUMAN LUNG JANNE HUKKANEN

  2001cites this paper
• Induction of cytochromes P450 1A1 and 1B1 by emodin in human lung adenocarcinoma cell line CL5.

  2001cites this paper
• CYP2D6 gene polymorphism in caucasian smokers: lung cancer susceptibility and phenotype-genotype relationships.

  2000cites this paper
• Variable Cytochrome P450 2D6 Expression and Metabolism of Codeine and Other Opioid Prodrugs: Implications for the Australian Anaesthetist

  2000cites this paper
• Porcine microsomal vitamin D(3) 25-hydroxylase (CYP2D25). Catalytic properties, tissue distribution, and comparison with human CYP2D6.

  2000cites this paper
• Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line.

  2000cites this paper
• Xenobiotic-metabolizing cytochrome P450 enzymes in human lung

  2000cites this paper
• Human cytochromes P450

  1999cites this paper
• Chapter 11 – Nitrosamines derived from nicotine and other tobacco alkaloids

  1999cites this paper
• Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue.

  1999cites this paper